Sanofi (STU:SNW2) Other Expense


STU:SNW2 Sanofi SA STU:SNW2
87 GF Score
Price €36.40
GF Value €52.99
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Sanofi Other Expense?

Other Expense only applies to insurance companies.

STU:SNW2
87GF Score
Sanofi SA STU:SNW2
Other Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sanofi (STU:SNW2) Overvalued in 2026?

Based on GuruFocus' analysis, Sanofi stock appears to be undervalued. The current stock price of €36.40 is trading 31.3% below its estimated GF Value™ of €52.99. GuruFocus considers Sanofi to be Possible Value Trap.

Key valuation signals for STU:SNW2:

  • Other Expense:
  • GF Value™: €52.99 vs. price of €36.40 (31.3% below fair value)
  • GF Score™: 87/100 with 2 warning signs

No single metric tells the full story. See the STU:SNW2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sanofi Business Description

Address 46, Avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
87GF Score

Get the complete analysis for STU:SNW2

Other Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€36.40
Price
€52.99
GF Value